In partnership with

Good Morning, Traders!…👋

U.S. stock futures are under pressure Friday as markets weigh the looming threat of a government shutdown and the Federal Reserve’s revised outlook for a higher interest rate path.

The Fed’s decision to raise its 2025 inflation forecast and scale back projections for rate cuts rattled Wall Street earlier this week, with Trump’s plans for tariffs, tax cuts, and deregulation cited as contributing factors.

Today’s focus shifts to the Commerce Department’s personal consumption expenditure (PCE) report, set for release at 8:30 a.m. ET. This key inflation gauge is expected to show a 0.2% rise in U.S. consumer spending for November, matching the previous month’s pace.

The data could provide further insights into how inflation may shape the Fed’s policy in the coming year. Traders are now pricing in fewer than two rate cuts by the end of 2025, following the Fed’s expected quarter-point cut earlier this week.

Happening Today

✓ 08:30 AM ET – Core PCE Price Index (MoM) (YoY) (Nov)

✓ 08:30 AM ET – GPCE Price index (MoM) (YoY) (Nov)

✓ 10:00 AM ET – Michigan Consumer Sentiment (Dec)

✓ 03:30 PM ET – CFTC Nasdaq 100 and S&P 500 speculative net positions

PREMARKET SNAPSHOT 📈

Market futures are down, with the S&P 500, Dow, and NASDAQ all showing significant declines.

Man Who Called Nvidia at $1.10 Says Buy This Now...

• This company signed a major deal with Apple

• Nvidia has invested more in this one company than any othe

• And its tech is found in products from Samsung and Google

Click here for details.

SECTOR SNAPSHOT✨

Yesterday markets displayed mixed performance with some sectors showing resilience while others remained under pressure. Consumer discretionary and financials managed slight gains, while technology stocks posted modest upward movement. However, sectors like consumer staples, health care, and materials saw declines, reflecting cautious sentiment. Real estate and energy also struggled, contributing to the overall market's uneven tone. Utilities offered some support, closing with a small gain.

PreMarket Unusual Volume Stocks

📈 My Size Inc (MYSZ) showed exceptional growth with a staggering 280.74% increase in its stock price, now at 5.14. The trading volume reached 18,278,133 shares, significantly surpassing its average volume of 118.64.

📈 Aptose Biosciences Inc (APTO) exhibited a notable 61.10% rise in its stock price, closing at 0.27. The trading volume soared to 32,940,306 shares, far exceeding the average volume of 1257.42.

📈 Helius Medical Technologies Inc (HSDT) recorded a strong performance with a 106.63% increase, bringing its stock price to 0.99. The trading volume was 8,070,140 shares, well above its average of 351.65.

📈 Foresight Autonomous Holdings Ltd ADR (FRSX) experienced a modest increase of 34.78% in its stock price, reaching 1.24. The trading volume hit 5,250,949 shares, significantly higher than its average volume of 253.50.

📈 Color Star Technology Co Ltd (ADD) recorded a slight increase of 9.72% in its stock price, now at 2.71. The trading volume stood at 3,017,161 shares, surpassing its average of 203.53.

Premarket Picks

Aptose Biosciences Inc. (APTO) saw a significant pre-market surge of 85.02%, with shares rising to $0.31. This increase followed the announcement that the Nasdaq Hearings Panel granted the company an extension to demonstrate compliance with all the necessary criteria for continued listing on The Nasdaq Stock Market.

Foresight Autonomous Holdings Ltd. (FRSX) experienced a pre-market gain of 46.74%, bringing its price to $1.35. The surge was triggered by news that its subsidiary, Eye-Net Mobile, entered a multi-phase agreement with SoftBank Corp and a prominent Japanese vehicle manufacturer.

Humacyte, Inc. (HUMA) saw its pre-market price rise by 45.95%, reaching $5.05 after the company received FDA approval for its SYMVESS treatment, designed for managing extremity vascular trauma.

Aadi Bioscience, Inc. (AADI) gained 23.27% in pre-market trading, pushing its price to $2.86. The surge came after the company announced a transformative deal involving in-licensing a novel ADC portfolio, the $100 million sale of FYARRO®, and a $100 million PIPE financing.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Evercore Inc. (EVR)

Analyst Firm: Keefe Bruyette
Upgrade: Market Perform to Outperform
Price Target: $339
Yesterday's Close: $270.57

Keefe Bruyette raised its rating on Evercore to Outperform from Market Perform, increasing its price target to $339 from $269.

Evercore Inc. (EVR), a premier global independent investment banking advisory firm, has analyst price targets ranging from a high of $400.00 to a low of $279.00. The median target is $325.00, with the average price target set at $332.29.

2. FedEx Corporation (FDX)

Analyst Firm: Loop Capital
Upgrade: Hold to Buy
Price Target: $365
Yesterday's Close: $275.88

Loop Capital upgraded FedEx to Buy from Hold, setting a new price target of $365, up from $288.

FedEx Corporation (FDX), which provides customers and businesses worldwide with a broad range of transportation, e-commerce, and business services, has a price target range with a high of $370.00 and a low of $200.00. The median target is $321.00, and the average target is $317.26.

3. Affirm Holdings, Inc. (AFRM)

Analyst Firm: JMP Securities
Upgrade: Market Perform to Outperform
Price Target: $78
Yesterday's Close: $63.00

JMP Securities analyst David Scharf raised Affirm's rating to Outperform from Market Perform, with a target price of $78.

Affirm Holdings, Inc. (AFRM), whose mission is to deliver honest financial products that improve lives, has a price target range with a high of $82.00, a low of $20.00, and an average target of $62.35. The median target stands at $74.00.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.